News – Page 606 – Endpoints News

Moderna says its mRNA flu vaccine cleared early studies, but comparisons with other vaccines drive stock down

4 years ago

Covid-19 roundup: UK preps for a wave of Omicron cases; Bourla suggests a fourth dose might be necessary

4 years ago

Snakebit Angion reports another miss for lead program, as biotech prepares to shift its 'primary focus'

4 years ago

Billionaire BioNTech backers have been kicking the tires at Novartis' big generics arm — report

4 years ago

Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the ...

4 years ago

GlaxoSmithKline enlisted Harris Poll for a severe asthma survey — results point to more outreach

4 years ago

Viatris and Biocon mull pooling their biosimilars into a $10B standalone company — report

4 years ago

Kenya to reduce import dependency with production of new site; Co-laboratory space to open in China

4 years ago

Recall report: Sandoz yanks 1 lot of enoxaparin after exposure to warm temperatures

4 years ago

Ever optimistic despite concerns, BrainStorm teams with Catalent to prep for possible approval for ALS drug

4 years ago

Fujifilm cracks open doors at its newest drug production site in the Netherlands

4 years ago

Taipei's Bora wants in on the CDMO game as report shows plenty of room for industry growth

4 years ago

Merck enlists Thermo Fisher to make Covid-19 antiviral molnupiravir for Canada, UK

4 years ago

Covid-19 manufacturing roundup: Covax, Indian manufacturer at odds over vaccine supply; EU planning surplus on shot ...

4 years ago

Totus pulls in $40M Series A with sights on PI3Kα; FDA asks Sesen for another trial after CRL, biotech says

4 years ago

Eir Ventures tops up life sciences fund with $138M for Nordic biotechs

4 years ago

With new pivotal data, uniQure and CSL Behring dash to the FDA with a potential blockbuster gene therapy for ...

4 years ago

Radius falters after a PhIII osteoporosis fail and a breast cancer disappointment, sending shares plummeting

4 years ago

Struggling Aprea wins a reprieve as FDA lifts one of the holds on their only drug

4 years ago

Will ‘original antigenic sin’ undermine Omicron boosters? New research suggests ‘no’

4 years ago

House almost unanimously passes bipartisan bill to pump $500M into ALS drug R&D

4 years ago

Promising to slim down and speed up, the ‘new’ J&J shakes up the executive committee ahead of the big split

4 years ago

Fledgling Stanford spinout promising 3D models of fully human tissue wins the backing of some big-time investors

4 years ago

Cingulate prices a downsized public offering as IPO party appears to die down

4 years ago

First page Previous page 603 604 605606607 608 609 Next page Last page